Mealey's (December 16, 2022, 12:41 PM EST) -- WILMINGTON, Del. — A federal judge in Delaware has found that two proposed generic drugs would not infringe one claim of a reissue patent covering a sleep disorder treatment and that the remaining claims and patents asserted in the case are invalid as obvious....